HOME >> MEDICINE >> NEWS
Timing of women's labor may determine effectiveness of pain medication

WINSTON-SALEM, N.C. Natural daily body rhythms may influence the effectiveness of spinal-epidural pain medication for women in labor, according to new research from Wake Forest University Baptist Medical Center. The study found that women who had day labor got longer pain relief than women with night labor with the same amount of labor pain medicine.

"Our research shows that the time of day that the medication is delivered is important in determining its effectiveness," said Peter H. Pan, M.D., an obstetrical anesthesiologist. "In the future, doctors may consider time of day, as well as patient's weight and other factors, when determining the best dose or method of drug delivery."

The study's goal was to determine if the body's natural internal rhythms can affect the effectiveness of pain medication for laboring women. The study, reported in the current issue of Anesthesiology, involved 77 women who were in labor with their first babies and requested spinal-epidural pain medication.

The research is part of the field of chronobiology that studies biologic rhythms. These rhythms include the circadian rhythm, the 24-hour body clock, and the ultradian rhythm, shorter-than-24-hour-cycles, which determine sleeping and eating patterns and can also affect blood pressure, heart rate and body temperature. Some rhythms are controlled by sunlight and others are controlled internally.

The researchers found that women who labored between noon and 6 p.m. got an average of 27 percent longer pain relief from a single dose of the spinal-epidural medication fentanyl than women whose labor was between 8 p.m. and 2 a.m. Fentanyl is one of the commonly used drugs for labor pain relief in the United States. However, this is one of the first studies to examine whether there are chronobiological variations in its effectiveness for labor pain relief.

"The right treatment given at the wrong time can be ineffective or create a crisis of escalating
'"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
15-Sep-2005


Page: 1 2

Related medicine news :

1. Timing of radiation treatments for colon cancer may need adjusting, Jefferson researchers say
2. Timing possible treatments against Alzheimers disease
3. Timing of introduction of gluten into infants diet associated with appearance of celiac disease
4. Moderate drinking lowers womens risk of heart attack
5. Prioritizing womens health
6. Updated guidelines advise focusing on womens lifetime heart risk
7. Extra cortisol protects womens mood under stress
8. Finger length ratio may predict womens sporting prowess
9. Weight worries affect womens motivation to stay smoke-free after pregnancy
10. Target womens depression to reduce disability from chronic conditions, suggests study
11. Race and income converge to shape womens experiences with advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Timing women labor may determine effectiveness pain medication

(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... November 27, 2014 Allowing children to help ... during school, helps give children responsibility, ownership, boosts self-esteem, and ... , Now, the real question is, how do you ... secret? According to a study published by Child Development Journal, ... a dramatic effect on a child’s willingness to lend a ...
(Date:11/27/2014)... 27, 2014 At The Little Gym, ... it came as no surprise when a recent study ... academic success. The Journal of Pediatrics found ... motor tasks during the school years may be important ... development.” The study monitored two groups of children; those ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... U.S. Food and Drug Administration (FDA) has issued ... Application (NDA) for AVP-825. AVP-825 is an investigational ... delivered intranasally utilizing a novel Breath Powered delivery ... letter, and consistent with the preliminary feedback announced ...
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
Cached News: